300 related articles for article (PubMed ID: 36567056)
1. Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects.
Ansari MF; Khan HY; Tabassum S; Arjmand F
Pharmacol Ther; 2023 Jan; 241():108335. PubMed ID: 36567056
[TBL] [Abstract][Full Text] [Related]
2. Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies.
Arjmand F; Yasir Khan H; Tabassum S
Chem Rec; 2023 Mar; 23(3):e202200247. PubMed ID: 36762719
[TBL] [Abstract][Full Text] [Related]
3. Alkaloid-metal based anticancer agents.
Chen ZF; Liu YC; Huang KB; Liang H
Curr Top Med Chem; 2013; 13(17):2104-15. PubMed ID: 23978139
[TBL] [Abstract][Full Text] [Related]
4. Metallo-Drugs in Cancer Therapy: Past, Present and Future.
Lucaciu RL; Hangan AC; Sevastre B; Oprean LS
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235023
[TBL] [Abstract][Full Text] [Related]
5. Advancements in the Use of Platinum Complexes as Anticancer Agents.
Sharma R; Singh VJ; Chawla PA
Anticancer Agents Med Chem; 2022; 22(5):821-835. PubMed ID: 34353272
[TBL] [Abstract][Full Text] [Related]
6. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
7. Progresses in TCM metal-based antitumour agents.
Chen ZF; Liang H
Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
[TBL] [Abstract][Full Text] [Related]
8. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Nardon C; Brustolin L; Fregona D
Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Role of Alkaloids and Alkaloid Derivatives in Cancer Management.
Olofinsan K; Abrahamse H; George BP
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513450
[TBL] [Abstract][Full Text] [Related]
10. The status of platinum anticancer drugs in the clinic and in clinical trials.
Wheate NJ; Walker S; Craig GE; Oun R
Dalton Trans; 2010 Sep; 39(35):8113-27. PubMed ID: 20593091
[TBL] [Abstract][Full Text] [Related]
11. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
12. Anticancer metallodrugs: where is the next cisplatin?
Hanif M; Hartinger CG
Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
[TBL] [Abstract][Full Text] [Related]
13. Current perspective of natural alkaloid carbazole and its derivatives as antitumor agents.
Shaikh MS; Karpoormath R; Thapliyal N; Rane RA; Palkar MB; Faya AM; Patel HM; Alwan WS; Jain K; Hampannavar GA
Anticancer Agents Med Chem; 2015; 15(8):1049-65. PubMed ID: 25584693
[TBL] [Abstract][Full Text] [Related]
14. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments in the Field of Tumor-Inhibiting Metal Complexes.
Galanski MS; Arion VB; Jakupec MA; Keppler BK
Curr Pharm Des; 2003; 9(25):2078-89. PubMed ID: 14529417
[TBL] [Abstract][Full Text] [Related]
16. Anticancer properties of complexes derived from bidentate ligands.
Ugwu DI; Conradie J
J Inorg Biochem; 2023 Sep; 246():112268. PubMed ID: 37301166
[TBL] [Abstract][Full Text] [Related]
17. Anticancer carbazole alkaloids and coumarins from Clausena plants: A review.
Huang L; Feng ZL; Wang YT; Lin LG
Chin J Nat Med; 2017 Dec; 15(12):881-888. PubMed ID: 29329644
[TBL] [Abstract][Full Text] [Related]
18. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
[TBL] [Abstract][Full Text] [Related]
19. New platinum antitumor complexes.
Kelland LR
Crit Rev Oncol Hematol; 1993 Dec; 15(3):191-219. PubMed ID: 8142057
[TBL] [Abstract][Full Text] [Related]
20. Metal complexes in cancer therapy - an update from drug design perspective.
Ndagi U; Mhlongo N; Soliman ME
Drug Des Devel Ther; 2017; 11():599-616. PubMed ID: 28424538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
